Cell Pathology

Adult sickle cell drug proves effective in young children

A new study shows that hydroxyurea is an efficient and safe treatment option for young children with sickle cell anemia, improving spleen function and reducing acute chest syndrome incidents

Circulating stem cells play small role in lung repair

A recent study found that circulating stem cells contribute less than 1% to lung repair, while most contributions come from lung-resident stem cells. The study also suggests a link between the number of Y-chromosome containing pneumocytes and acute cellular rejection in lung tissue.

Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

New insight into Huntington's disease pathology

Studies in mice with genetically engineered mutant huntingtin protein found that widespread production led to locomotor problems, neurodegeneration, and abnormal brain connections. Conversely, restricted production showed little difference from normal mice, suggesting cellular interactions play a significant role in HD pathogenesis.

Rice cartilage experts win $1.5M NIH grant to bioengineer TMJ discs

Researchers at Rice University aim to create implantable TMJ discs grown from patient cells, offering a potential alternative to transplantation. The goal is to provide a treatment option for the nearly 11 million Americans suffering from TMJ disorders.

UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders

Researchers at UT Southwestern have made significant progress in understanding lipodystrophies, rare disorders characterized by partial or total loss of fat tissues. Recent studies have identified gene mutations and novel therapeutic approaches for these patients, which may also be applicable to obese individuals with abnormal fat dist...

Bleeding disorder tied to defect in cellular transport mechanism

A study has identified a genetic mutation in MCFD2 that causes a rare bleeding disorder by disrupting the transport of clotting factors V and VIII. The researchers propose a new therapeutic target, suggesting a potential alternative to existing anticoagulants.